等待名单上超过米兰标准的肝细胞癌的全身治疗:是时候进行新辅助治疗了吗?

Hepatoma Research Pub Date : 2023-01-01 DOI:10.20517/2394-5079.2023.38

B. Magro, M. Triolo, C. Celsa, D. Pagano, G. Cabibbo, C. Cammà, S. Fagiuoli, S. Gruttadauria

{"title":"等待名单上超过米兰标准的肝细胞癌的全身治疗:是时候进行新辅助治疗了吗?","authors":"B. Magro, M. Triolo, C. Celsa, D. Pagano, G. Cabibbo, C. Cammà, S. Fagiuoli, S. Gruttadauria","doi":"10.20517/2394-5079.2023.38","DOIUrl":null,"url":null,"abstract":"© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.","PeriodicalId":12959,"journal":{"name":"Hepatoma Research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systemic treatment for hepatocellular carcinoma beyond milan criteria on the waitlist: is it time for a neoadjuvant therapy?\",\"authors\":\"B. Magro, M. Triolo, C. Celsa, D. Pagano, G. Cabibbo, C. Cammà, S. Fagiuoli, S. Gruttadauria\",\"doi\":\"10.20517/2394-5079.2023.38\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.\",\"PeriodicalId\":12959,\"journal\":{\"name\":\"Hepatoma Research\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hepatoma Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.20517/2394-5079.2023.38\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatoma Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20517/2394-5079.2023.38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

©作者2023。开放获取本文遵循知识共享署名4.0国际许可协议(https://creativecommons.org/licenses/by/4.0/)，该协议允许不受限制地使用、共享、改编、分发和复制，以任何媒介或格式，用于任何目的，甚至商业目的，只要您适当地注明原作者和来源，提供知识共享许可协议的链接，并注明是否进行了更改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Systemic treatment for hepatocellular carcinoma beyond milan criteria on the waitlist: is it time for a neoadjuvant therapy?

© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hepatoma Research

自引率

0.00%

发文量